CTOs on the Move

GenMark Diagnostics

www.genmarkdx.com

 
In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.genmarkdx.com
  • 5964 La Place Court Suite 100
    Carlsbad, CA USA 92008
  • Phone: 760.448.4300

Executives

Name Title Contact Details

Similar Companies

Isokinetics

Isokinetics is a Grannis, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Incisive Surgical

Incisive Surgical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InfraScan

InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.

Cardiac Dimensions

Cardiac Dimensions® is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation.

ProAct Pharmacy Services

ProAct Pharmacy Services is a Gouverneur, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.